MPM BIOIMPACT LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1687078 BOSTON, MA

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$57,322,211

+$17,971,942 QoQ

Shares Held

3,073,577

-6.8% QoQ

Ownership

2.16%

of shares outstanding

% of Portfolio

3.50%

of 13F equity value

Holder Rank

#10

of 216 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. TRVI ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGEM	Cullinan Therapeutics, Inc.	9,731,341	$177,207,719
2	AKTS	Aktis Oncology, Inc.	4,835,872	$155,860,154
3	RVMD	Revolution Medicines, Inc.	492,483	$92,232,216
4	CORT	Corcept Therapeutics Inc	771,028	$67,040,884
5	EWTX	Edgewise Therapeutics, Inc.	1,620,780	$65,852,291
6	TVTX	Travere Therapeutics, Inc.	1,122,731	$63,782,348
7	DBVT	DBV Technologies S.A.	3,666,284	$60,127,057
8	TRVI	Trevi Therapeutics, Inc. This page	3,073,577	$57,322,211

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$57,322,211	3,073,577	-6.8%	Shares	Sole	2026-08-14
2026-03-31	$39,350,269	3,298,430	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$41,154,329	3,287,087	-3.5%	Shares	Sole	2026-02-17
2025-09-30	$31,173,638	3,406,955	0.0%	Shares	Sole	2025-11-14
2025-06-30	$18,636,043	3,406,955	-0.6%	Shares	Sole	2025-08-14
2025-03-31	$21,564,422	3,428,366	+10.8%	Shares	Sole	2025-05-15
2024-12-31	$12,750,971	3,094,896	+101.2%	Shares	Sole	2025-02-14
2024-09-30	$5,138,646	1,538,517	+1.9%	Shares	Sole	2024-11-13
2024-06-30	$4,500,318	1,510,174	+12.6%	Shares	Sole	2024-08-14
2024-03-31	$4,626,312	1,340,960	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.